Related Experiment Video
Updated: Jun 30, 2025
09:43
Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
8.1K
Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example
Alexander R Evans1, Kiana Y Prather1, James Battiste1
1Department of Neurosurgery, University of Oklahoma, Oklahoma City, Oklahoma.
World Neurosurgery
|March 15, 2024
Summary
Oligosarcoma is a rare but aggressive central nervous system (CNS) cancer that can develop after oligodendroglioma surgery. Early, aggressive treatment including resection and chemoradiation is recommended for this unfavorable neuro-oncologic disease.
Area of Science:
- Neuro-oncology
- Central Nervous System Neoplasms
- Rare Cancers
Background:
- Oligosarcoma is a rare central nervous system (CNS) neoplasm with a unique genetic profile and aggressive clinical behavior.
- It may arise following oligodendroglioma resection, presenting a significant challenge in neuro-oncologic disease management.
- This study emphasizes the clinical and prognostic features of this unusual and unfavorable CNS malignancy.
Approach:
- Systematic literature review of relevant publications.
- Inclusion of an illustrative case example to highlight clinical and pathological features.
- Analysis of genetic profiles and treatment outcomes in oligosarcoma.
Key Points:
- Oligosarcoma shares genetic features with oligodendroglioma, including 1p/19q codeletion and H3K27me3 expression.
- Median survival after oligosarcoma diagnosis is poor, approximately 1.3 years.
- A strong association exists between oligosarcoma and previously resected oligodendroglioma or oligoastrocytoma.
Conclusions:
- Oligosarcoma is a prognostically unfavorable CNS neoplasm.
- Aggressive treatment, including gross total resection and adjuvant chemoradiation, is recommended.
- Further research is needed to establish optimal treatment protocols for this rare CNS malignancy.
